img

Global Etoricoxib Tablet Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Etoricoxib Tablet Market Insights, Forecast to 2034

Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
Global Etoricoxib Tablet market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Etoricoxib Tablet industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Etoricoxib Tablet key manufacturers include Merk, AdvaCare, Alpha Drugs, BSA Pharma Inc., Vibcare Pharma Pvt Ltd, WELLONA PHARMA, Incepta Pharmaceuticals Ltd., LXIR Medilabs and Swissche Healthcare, etc. Merk, AdvaCare, Alpha Drugs are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Etoricoxib Tablet were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Etoricoxib Tablet market and estimated to attract more attentions from industry insiders and investors.
Etoricoxib Tablet can be divided into 60mg, 90mg and 120mg,, etc. 60mg is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Etoricoxib Tablet is widely used in various fields, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Others, etc. Osteoarthritis (OA) provides greatest supports to the Etoricoxib Tablet industry development. In 2022, global % sales of Etoricoxib Tablet went into Osteoarthritis (OA) filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Etoricoxib Tablet market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Etoricoxib Tablet market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merk
AdvaCare
Alpha Drugs
BSA Pharma Inc.
Vibcare Pharma Pvt Ltd
WELLONA PHARMA
Incepta Pharmaceuticals Ltd.
LXIR Medilabs
Swissche Healthcare
MK Medicine
QILU PHARMACEUTICAL CO.,LTD
Segment by Type
60mg
90mg
120mg

Segment by Application


Osteoarthritis (OA)
Rheumatoid Arthritis (RA)
Ankylosing Spondylitis
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Etoricoxib Tablet plant distribution, commercial date of Etoricoxib Tablet, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Etoricoxib Tablet introduction, etc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Etoricoxib Tablet
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Etoricoxib Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Etoricoxib Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 60mg
1.2.3 90mg
1.2.4 120mg
1.3 Market by Application
1.3.1 Global Etoricoxib Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Osteoarthritis (OA)
1.3.3 Rheumatoid Arthritis (RA)
1.3.4 Ankylosing Spondylitis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Etoricoxib Tablet Sales Estimates and Forecasts 2018-2029
2.2 Global Etoricoxib Tablet Revenue by Region
2.2.1 Global Etoricoxib Tablet Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Etoricoxib Tablet Revenue by Region (2018-2024)
2.2.3 Global Etoricoxib Tablet Revenue by Region (2024-2029)
2.2.4 Global Etoricoxib Tablet Revenue Market Share by Region (2018-2029)
2.3 Global Etoricoxib Tablet Sales Estimates and Forecasts 2018-2029
2.4 Global Etoricoxib Tablet Sales by Region
2.4.1 Global Etoricoxib Tablet Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Etoricoxib Tablet Sales by Region (2018-2024)
2.4.3 Global Etoricoxib Tablet Sales by Region (2024-2029)
2.4.4 Global Etoricoxib Tablet Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Etoricoxib Tablet Sales by Manufacturers
3.1.1 Global Etoricoxib Tablet Sales by Manufacturers (2018-2024)
3.1.2 Global Etoricoxib Tablet Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Etoricoxib Tablet in 2022
3.2 Global Etoricoxib Tablet Revenue by Manufacturers
3.2.1 Global Etoricoxib Tablet Revenue by Manufacturers (2018-2024)
3.2.2 Global Etoricoxib Tablet Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Etoricoxib Tablet Revenue in 2022
3.3 Global Key Players of Etoricoxib Tablet, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Etoricoxib Tablet Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Etoricoxib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Etoricoxib Tablet, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Etoricoxib Tablet, Product Offered and Application
3.8 Global Key Manufacturers of Etoricoxib Tablet, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Etoricoxib Tablet Sales by Type
4.1.1 Global Etoricoxib Tablet Historical Sales by Type (2018-2024)
4.1.2 Global Etoricoxib Tablet Forecasted Sales by Type (2024-2029)
4.1.3 Global Etoricoxib Tablet Sales Market Share by Type (2018-2029)
4.2 Global Etoricoxib Tablet Revenue by Type
4.2.1 Global Etoricoxib Tablet Historical Revenue by Type (2018-2024)
4.2.2 Global Etoricoxib Tablet Forecasted Revenue by Type (2024-2029)
4.2.3 Global Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Etoricoxib Tablet Price by Type
4.3.1 Global Etoricoxib Tablet Price by Type (2018-2024)
4.3.2 Global Etoricoxib Tablet Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Etoricoxib Tablet Sales by Application
5.1.1 Global Etoricoxib Tablet Historical Sales by Application (2018-2024)
5.1.2 Global Etoricoxib Tablet Forecasted Sales by Application (2024-2029)
5.1.3 Global Etoricoxib Tablet Sales Market Share by Application (2018-2029)
5.2 Global Etoricoxib Tablet Revenue by Application
5.2.1 Global Etoricoxib Tablet Historical Revenue by Application (2018-2024)
5.2.2 Global Etoricoxib Tablet Forecasted Revenue by Application (2024-2029)
5.2.3 Global Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Etoricoxib Tablet Price by Application
5.3.1 Global Etoricoxib Tablet Price by Application (2018-2024)
5.3.2 Global Etoricoxib Tablet Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Etoricoxib Tablet Market Size by Type
6.1.1 US & Canada Etoricoxib Tablet Sales by Type (2018-2029)
6.1.2 US & Canada Etoricoxib Tablet Revenue by Type (2018-2029)
6.2 US & Canada Etoricoxib Tablet Market Size by Application
6.2.1 US & Canada Etoricoxib Tablet Sales by Application (2018-2029)
6.2.2 US & Canada Etoricoxib Tablet Revenue by Application (2018-2029)
6.3 US & Canada Etoricoxib Tablet Market Size by Country
6.3.1 US & Canada Etoricoxib Tablet Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Etoricoxib Tablet Sales by Country (2018-2029)
6.3.3 US & Canada Etoricoxib Tablet Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Etoricoxib Tablet Market Size by Type
7.1.1 Europe Etoricoxib Tablet Sales by Type (2018-2029)
7.1.2 Europe Etoricoxib Tablet Revenue by Type (2018-2029)
7.2 Europe Etoricoxib Tablet Market Size by Application
7.2.1 Europe Etoricoxib Tablet Sales by Application (2018-2029)
7.2.2 Europe Etoricoxib Tablet Revenue by Application (2018-2029)
7.3 Europe Etoricoxib Tablet Market Size by Country
7.3.1 Europe Etoricoxib Tablet Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Etoricoxib Tablet Sales by Country (2018-2029)
7.3.3 Europe Etoricoxib Tablet Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Etoricoxib Tablet Market Size
8.1.1 China Etoricoxib Tablet Sales (2018-2029)
8.1.2 China Etoricoxib Tablet Revenue (2018-2029)
8.2 China Etoricoxib Tablet Market Size by Application
8.2.1 China Etoricoxib Tablet Sales by Application (2018-2029)
8.2.2 China Etoricoxib Tablet Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Etoricoxib Tablet Market Size by Type
9.1.1 Asia Etoricoxib Tablet Sales by Type (2018-2029)
9.1.2 Asia Etoricoxib Tablet Revenue by Type (2018-2029)
9.2 Asia Etoricoxib Tablet Market Size by Application
9.2.1 Asia Etoricoxib Tablet Sales by Application (2018-2029)
9.2.2 Asia Etoricoxib Tablet Revenue by Application (2018-2029)
9.3 Asia Etoricoxib Tablet Sales by Region
9.3.1 Asia Etoricoxib Tablet Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Etoricoxib Tablet Revenue by Region (2018-2029)
9.3.3 Asia Etoricoxib Tablet Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Etoricoxib Tablet Market Size by Type
10.1.1 Middle East, Africa and Latin America Etoricoxib Tablet Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Etoricoxib Tablet Market Size by Application
10.2.1 Middle East, Africa and Latin America Etoricoxib Tablet Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Etoricoxib Tablet Sales by Country
10.3.1 Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Etoricoxib Tablet Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merk
11.1.1 Merk Company Information
11.1.2 Merk Overview
11.1.3 Merk Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merk Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merk Recent Developments
11.2 AdvaCare
11.2.1 AdvaCare Company Information
11.2.2 AdvaCare Overview
11.2.3 AdvaCare Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AdvaCare Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AdvaCare Recent Developments
11.3 Alpha Drugs
11.3.1 Alpha Drugs Company Information
11.3.2 Alpha Drugs Overview
11.3.3 Alpha Drugs Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Alpha Drugs Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alpha Drugs Recent Developments
11.4 BSA Pharma Inc.
11.4.1 BSA Pharma Inc. Company Information
11.4.2 BSA Pharma Inc. Overview
11.4.3 BSA Pharma Inc. Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 BSA Pharma Inc. Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BSA Pharma Inc. Recent Developments
11.5 Vibcare Pharma Pvt Ltd
11.5.1 Vibcare Pharma Pvt Ltd Company Information
11.5.2 Vibcare Pharma Pvt Ltd Overview
11.5.3 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vibcare Pharma Pvt Ltd Recent Developments
11.6 WELLONA PHARMA
11.6.1 WELLONA PHARMA Company Information
11.6.2 WELLONA PHARMA Overview
11.6.3 WELLONA PHARMA Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 WELLONA PHARMA Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 WELLONA PHARMA Recent Developments
11.7 Incepta Pharmaceuticals Ltd.
11.7.1 Incepta Pharmaceuticals Ltd. Company Information
11.7.2 Incepta Pharmaceuticals Ltd. Overview
11.7.3 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Incepta Pharmaceuticals Ltd. Recent Developments
11.8 LXIR Medilabs
11.8.1 LXIR Medilabs Company Information
11.8.2 LXIR Medilabs Overview
11.8.3 LXIR Medilabs Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 LXIR Medilabs Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LXIR Medilabs Recent Developments
11.9 Swissche Healthcare
11.9.1 Swissche Healthcare Company Information
11.9.2 Swissche Healthcare Overview
11.9.3 Swissche Healthcare Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Swissche Healthcare Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Swissche Healthcare Recent Developments
11.10 MK Medicine
11.10.1 MK Medicine Company Information
11.10.2 MK Medicine Overview
11.10.3 MK Medicine Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 MK Medicine Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MK Medicine Recent Developments
11.11 QILU PHARMACEUTICAL CO.,LTD
11.11.1 QILU PHARMACEUTICAL CO.,LTD Company Information
11.11.2 QILU PHARMACEUTICAL CO.,LTD Overview
11.11.3 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 QILU PHARMACEUTICAL CO.,LTD Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Etoricoxib Tablet Industry Chain Analysis
12.2 Etoricoxib Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Etoricoxib Tablet Production Mode & Process
12.4 Etoricoxib Tablet Sales and Marketing
12.4.1 Etoricoxib Tablet Sales Channels
12.4.2 Etoricoxib Tablet Distributors
12.5 Etoricoxib Tablet Customers
13 Market Dynamics
13.1 Etoricoxib Tablet Industry Trends
13.2 Etoricoxib Tablet Market Drivers
13.3 Etoricoxib Tablet Market Challenges
13.4 Etoricoxib Tablet Market Restraints
14 Key Findings in The Global Etoricoxib Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Etoricoxib Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 60mg
Table 3. Major Manufacturers of 90mg
Table 4. Major Manufacturers of 120mg
Table 5. Global Etoricoxib Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Etoricoxib Tablet Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Etoricoxib Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Etoricoxib Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Etoricoxib Tablet Revenue Market Share by Region (2018-2024)
Table 10. Global Etoricoxib Tablet Revenue Market Share by Region (2024-2029)
Table 11. Global Etoricoxib Tablet Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Etoricoxib Tablet Sales by Region (2018-2024) & (K Units)
Table 13. Global Etoricoxib Tablet Sales by Region (2024-2029) & (K Units)
Table 14. Global Etoricoxib Tablet Sales Market Share by Region (2018-2024)
Table 15. Global Etoricoxib Tablet Sales Market Share by Region (2024-2029)
Table 16. Global Etoricoxib Tablet Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Etoricoxib Tablet Sales Share by Manufacturers (2018-2024)
Table 18. Global Etoricoxib Tablet Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Etoricoxib Tablet Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Etoricoxib Tablet, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Etoricoxib Tablet Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Etoricoxib Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Etoricoxib Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Etoricoxib Tablet as of 2022)
Table 24. Global Key Manufacturers of Etoricoxib Tablet, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Etoricoxib Tablet, Product Offered and Application
Table 26. Global Key Manufacturers of Etoricoxib Tablet, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 29. Global Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 30. Global Etoricoxib Tablet Sales Share by Type (2018-2024)
Table 31. Global Etoricoxib Tablet Sales Share by Type (2024-2029)
Table 32. Global Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Etoricoxib Tablet Revenue Share by Type (2018-2024)
Table 35. Global Etoricoxib Tablet Revenue Share by Type (2024-2029)
Table 36. Etoricoxib Tablet Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Etoricoxib Tablet Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 39. Global Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 40. Global Etoricoxib Tablet Sales Share by Application (2018-2024)
Table 41. Global Etoricoxib Tablet Sales Share by Application (2024-2029)
Table 42. Global Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Etoricoxib Tablet Revenue Share by Application (2018-2024)
Table 45. Global Etoricoxib Tablet Revenue Share by Application (2024-2029)
Table 46. Etoricoxib Tablet Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Etoricoxib Tablet Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Etoricoxib Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Etoricoxib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Etoricoxib Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Etoricoxib Tablet Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Etoricoxib Tablet Sales by Country (2024-2029) & (K Units)
Table 61. Europe Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 62. Europe Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 63. Europe Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 66. Europe Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 67. Europe Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Etoricoxib Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Etoricoxib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Etoricoxib Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Etoricoxib Tablet Sales by Country (2018-2024) & (K Units)
Table 73. Europe Etoricoxib Tablet Sales by Country (2024-2029) & (K Units)
Table 74. China Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 75. China Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 76. China Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 79. China Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 80. China Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 83. Asia Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 84. Asia Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 87. Asia Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 88. Asia Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Etoricoxib Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Etoricoxib Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Etoricoxib Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Etoricoxib Tablet Sales by Region (2018-2024) & (K Units)
Table 94. Asia Etoricoxib Tablet Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Etoricoxib Tablet Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Etoricoxib Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Etoricoxib Tablet Sales by Country (2024-2029) & (K Units)
Table 108. Merk Company Information
Table 109. Merk Description and Major Businesses
Table 110. Merk Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Merk Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Merk Recent Developments
Table 113. AdvaCare Company Information
Table 114. AdvaCare Description and Major Businesses
Table 115. AdvaCare Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AdvaCare Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AdvaCare Recent Developments
Table 118. Alpha Drugs Company Information
Table 119. Alpha Drugs Description and Major Businesses
Table 120. Alpha Drugs Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Alpha Drugs Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Alpha Drugs Recent Developments
Table 123. BSA Pharma Inc. Company Information
Table 124. BSA Pharma Inc. Description and Major Businesses
Table 125. BSA Pharma Inc. Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. BSA Pharma Inc. Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. BSA Pharma Inc. Recent Developments
Table 128. Vibcare Pharma Pvt Ltd Company Information
Table 129. Vibcare Pharma Pvt Ltd Description and Major Businesses
Table 130. Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Vibcare Pharma Pvt Ltd Recent Developments
Table 133. WELLONA PHARMA Company Information
Table 134. WELLONA PHARMA Description and Major Businesses
Table 135. WELLONA PHARMA Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. WELLONA PHARMA Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. WELLONA PHARMA Recent Developments
Table 138. Incepta Pharmaceuticals Ltd. Company Information
Table 139. Incepta Pharmaceuticals Ltd. Description and Major Businesses
Table 140. Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Incepta Pharmaceuticals Ltd. Recent Developments
Table 143. LXIR Medilabs Company Information
Table 144. LXIR Medilabs Description and Major Businesses
Table 145. LXIR Medilabs Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. LXIR Medilabs Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. LXIR Medilabs Recent Developments
Table 148. Swissche Healthcare Company Information
Table 149. Swissche Healthcare Description and Major Businesses
Table 150. Swissche Healthcare Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Swissche Healthcare Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Swissche Healthcare Recent Developments
Table 153. MK Medicine Company Information
Table 154. MK Medicine Description and Major Businesses
Table 155. MK Medicine Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. MK Medicine Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. MK Medicine Recent Developments
Table 158. QILU PHARMACEUTICAL CO.,LTD Company Information
Table 159. QILU PHARMACEUTICAL CO.,LTD Description and Major Businesses
Table 160. QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. QILU PHARMACEUTICAL CO.,LTD Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Etoricoxib Tablet Distributors List
Table 166. Etoricoxib Tablet Customers List
Table 167. Etoricoxib Tablet Market Trends
Table 168. Etoricoxib Tablet Market Drivers
Table 169. Etoricoxib Tablet Market Challenges
Table 170. Etoricoxib Tablet Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Etoricoxib Tablet Product Picture
Figure 2. Global Etoricoxib Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Etoricoxib Tablet Market Share by Type in 2022 & 2029
Figure 4. 60mg Product Picture
Figure 5. 90mg Product Picture
Figure 6. 120mg Product Picture
Figure 7. Global Etoricoxib Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Etoricoxib Tablet Market Share by Application in 2022 & 2029
Figure 9. Osteoarthritis (OA)
Figure 10. Rheumatoid Arthritis (RA)
Figure 11. Ankylosing Spondylitis
Figure 12. Others
Figure 13. Etoricoxib Tablet Report Years Considered
Figure 14. Global Etoricoxib Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Etoricoxib Tablet Revenue 2018-2029 (US$ Million)
Figure 16. Global Etoricoxib Tablet Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Etoricoxib Tablet Revenue Market Share by Region (2018-2029)
Figure 18. Global Etoricoxib Tablet Sales 2018-2029 ((K Units)
Figure 19. Global Etoricoxib Tablet Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Etoricoxib Tablet Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Etoricoxib Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Etoricoxib Tablet Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Etoricoxib Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Etoricoxib Tablet Sales YoY (2018-2029) & (K Units)
Figure 25. China Etoricoxib Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Etoricoxib Tablet Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Etoricoxib Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Etoricoxib Tablet Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Etoricoxib Tablet Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Etoricoxib Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Etoricoxib Tablet in the World: Market Share by Etoricoxib Tablet Revenue in 2022
Figure 32. Global Etoricoxib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 34. Global Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 35. Global Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 36. Global Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Etoricoxib Tablet Revenue Share by Country (2018-2029)
Figure 42. US & Canada Etoricoxib Tablet Sales Share by Country (2018-2029)
Figure 43. U.S. Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 46. Europe Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 47. Europe Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 48. Europe Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 49. Europe Etoricoxib Tablet Revenue Share by Country (2018-2029)
Figure 50. Europe Etoricoxib Tablet Sales Share by Country (2018-2029)
Figure 51. Germany Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 52. France Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 56. China Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 57. China Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 58. China Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 59. China Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 60. Asia Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 61. Asia Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 62. Asia Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 63. Asia Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 64. Asia Etoricoxib Tablet Revenue Share by Region (2018-2029)
Figure 65. Asia Etoricoxib Tablet Sales Share by Region (2018-2029)
Figure 66. Japan Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 70. India Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Etoricoxib Tablet Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Etoricoxib Tablet Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Etoricoxib Tablet Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Etoricoxib Tablet Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Etoricoxib Tablet Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Etoricoxib Tablet Sales Share by Country (2018-2029)
Figure 77. Brazil Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Etoricoxib Tablet Revenue (2018-2029) & (US$ Million)
Figure 82. Etoricoxib Tablet Value Chain
Figure 83. Etoricoxib Tablet Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries